Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 173

1.
2.

Metabolic and cardiovascular effects of carvedilol and atenolol in non-insulin-dependent diabetes mellitus and hypertension. A randomized, controlled trial.

Giugliano D, Acampora R, Marfella R, De Rosa N, Ziccardi P, Ragone R, De Angelis L, D'Onofrio F.

Ann Intern Med. 1997 Jun 15;126(12):955-9.

PMID:
9182472
3.

Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.

Bakris GL, Fonseca V, Katholi RE, McGill JB, Messerli FH, Phillips RA, Raskin P, Wright JT Jr, Oakes R, Lukas MA, Anderson KM, Bell DS; GEMINI Investigators.

JAMA. 2004 Nov 10;292(18):2227-36.

PMID:
15536109
4.

Demographic analyses of the effects of carvedilol vs metoprolol on glycemic control and insulin sensitivity in patients with type 2 diabetes and hypertension in the Glycemic Effects in Diabetes Mellitus: Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) study.

Phillips RA, Fonseca V, Katholi RE, McGill JB, Messerli FH, Bell DS, Raskin P, Wright JT Jr, Iyengar M, Anderson KM, Lukas MA, Bakris GL; GEMINI Investigators.

J Cardiometab Syndr. 2008 Fall;3(4):211-7. doi: 10.1111/j.1559-4572.2008.00017.x.

5.
6.

How safe is carvedilol in NIDDM patients with hypertension?

Choudhury D, Misra A.

Natl Med J India. 1998 May-Jun;11(3):130-1. No abstract available.

PMID:
9707705
7.

Comparison of carvedilol and metoprolol on serum lipid concentration in diabetic hypertensive patients.

Bell DS, Bakris GL, McGill JB.

Diabetes Obes Metab. 2009 Mar;11(3):234-8. doi: 10.1111/j.1463-1326.2008.00927.x. Epub 2008 Jun 17.

PMID:
18564334
8.

Carvedilol.

Frishman WH.

N Engl J Med. 1998 Dec 10;339(24):1759-65. Review. No abstract available.

PMID:
9845712
9.
10.

Carvedilol, metoprolol, and insulin resistance.

Gonzalez-Feldman E.

JAMA. 2005 Mar 9;293(10):1190; author reply 1190. No abstract available.

PMID:
15755941
11.

Comparison of the antihypertensive effects of carvedilol and metoprolol on resting and exercise blood pressure.

Franz IW, Agrawal B, Wiewel D, Ketelhut R.

Clin Investig. 1992;70 Suppl 1:S53-7.

PMID:
1350485
12.

Effects of carvedilol versus metoprolol on endothelial function and oxidative stress in patients with type 2 diabetes mellitus.

Bank AJ, Kelly AS, Thelen AM, Kaiser DR, Gonzalez-Campoy JM.

Am J Hypertens. 2007 Jul;20(7):777-83.

PMID:
17586413
13.

Body weight changes with beta-blocker use: results from GEMINI.

Messerli FH, Bell DS, Fonseca V, Katholi RE, McGill JB, Phillips RA, Raskin P, Wright JT Jr, Bangalore S, Holdbrook FK, Lukas MA, Anderson KM, Bakris GL; GEMINI Investigators.

Am J Med. 2007 Jul;120(7):610-5.

PMID:
17602935
14.

Beta-blockers have a beneficial effect upon endothelial function and microalbuminuria in African-American subjects with diabetes and hypertension.

Jawa A, Nachimuthu S, Pendergrass M, Asnani S, Fonseca V.

J Diabetes Complications. 2008 Sep-Oct;22(5):303-8. doi: 10.1016/j.jdiacomp.2007.05.003. Epub 2008 Apr 16.

15.

[Alpha beta-blockers for patients with hypertension].

Mizuta Y, Imaizumi T.

Nihon Rinsho. 2006 Aug;64 Suppl 6:305-9. Review. Japanese. No abstract available.

PMID:
16981560
16.

The rationale and design of the Glycemic Effects in Diabetes Mellitus Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) trial.

Bakris GL, Bell DS, Fonseca V, Katholi R, McGill J, Phillips R, Raskin P, Wright JT Jr, Iyengar M, Holeslaw T, Anderson KM; GEMINI Investigators.

J Diabetes Complications. 2005 Mar-Apr;19(2):74-9.

PMID:
15745836
17.

Differential effect of beta-blocker therapy on insulin resistance as a function of insulin sensitizer use: results from GEMINI.

Fonseca V, Bakris GL, Bell DS, McGill JB, Raskin P, Messerli FH, Phillips RA, Katholi RE, Wright JT Jr, Waterhouse B, Lukas MA, Anderson KM; GEMINI Investigators.

Diabet Med. 2007 Jul;24(7):759-63. Epub 2007 Apr 19.

PMID:
17451422
18.

[For the first time beta blockers are in direct comparison With carvedilol weak hearts beat longer].

[No authors listed]

MMW Fortschr Med. 2003 Jul 10;145(27-28):60. German. No abstract available.

PMID:
14587195
19.

Influence of salt intake on the antihypertensive effect of carvedilol.

Ruilope LM, Lahera V.

J Hypertens Suppl. 1993 Jun;11(4):S17-9.

PMID:
8104238
20.

Comparison of the effects of carvedilol and nifedipine in patients with essential hypertension and non-insulin-dependent diabetes mellitus.

Albergati F, PaternĂ³ E, Venuti RP, Boeri D, Lombardo I, Semino S, Viviani GL, Adezati L.

J Cardiovasc Pharmacol. 1992;19 Suppl 1:S86-9.

PMID:
1378156

Supplemental Content

Support Center